China Has An Average 1.3 Million Active And 650,000 Infectious TB Cases
This article was originally published in PharmAsia News
Executive Summary
Between 2001 and 2010, China annually had 1.3 million active tuberculosis cases and 650,000 infectious tuberculosis cases, of which 120,000 are emerging multi-drug-resistant tuberculosis (XDR-TB) patients, stated China's CDC senior officer Chen MingTing at the country's first tuberculosis prevention and treatment charity event
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.